News Focus
News Focus
icon url

namtae

09/24/18 8:03 AM

#18455 RE: steadyhand #18454

Interesting

The trials will be conducted in the US as well as sites A and B in the Ukraine.



Sounds like they havent been conducted 8 months later!

Also, the Ukraine? lol I speculated something like this, like in south america.

Gee, what happened to Greenville? - disaster!!

Isnt it interesting how Oncolix hasnt informed its shareholders but a MB poster found this information elsewhere
icon url

AltJactUp

09/24/18 10:41 AM

#18461 RE: steadyhand #18454

Thanks for posting Steadyhand.
icon url

Rat Fink

09/24/18 10:47 PM

#18470 RE: steadyhand #18454

9/17/18 CLINICAL ACCELERATOR COLLABORATION_WITH_ONCOLIX_FOR_DEVELOPING_PROLANTA!!!_https://clinaccel.net/

icon url

reaper247

09/25/18 2:55 AM

#18471 RE: steadyhand #18454

Outstanding DD steadyhand.

Early DD on stocks like ONCX, is much more valuable than the comments that follow after the fact.

Cleary Oncolix is expanding research for Prolanta, not just initiating it.

ONCX has a worldwide patent portfolio that includes Europe, the UK, France, Germany etc…

Common sense would dictate that an effort to clear regulatory hurtles internationally, is a good thing for ONCX shareholders.

Thanks for posting.

IMO and FWIW.